Dosing & Uses
Ulcerative Colitis
Pending FDA approval for adults with moderately-to-severely active ulcerative colitis (UC)
Next:
Pharmacology
Mechanism of Action
Sphingosine 1-phosphate (S1P) receptor 1 modulator that binds with high affinity to S1P receptors 1, 4, and 5
Blocks capacity of lymphocytes to regress from lymph nodes, reducing number of lymphocytes in peripheral blood to decrease inflammation
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
